Accelerate
Dandelion Health accelerates clinical development and commercialization by combining proprietary AI tools with the richest source of real world patient data.
Deeper, Regulatory-Grade Insights from Real World Patient Data
Go beyond traditional real world data to see the full patient picture.
Dandelion’s multimodal Real World Data Platform brings together clinical notes, images and waveforms from millions of patient records for the most comprehensive view of disease progression, treatment efficacy, and individual patient outcomes.
Unlock Novel Insights with Dandelion’s Clinical AI Marketplace
Dandelion’s Clinical AI Marketplace allows researchers to unlock the potential of RWD by transforming unstructured clinical notes, images, and waveforms into structured, research-ready data using a suite of rigorously vetted AI algorithms.
Solutions tailored to each stage of the product development lifecycle
Life Sciences
-
Uncover novel insights into disease mechanisms, identify potential therapeutic targets, and streamline early clinical research with Dandelion’s Early Clinical Solutions.
-
Optimize the pool of eligible patients, reduce the need for costly protocol revisions and accelerate the time to clinical trial initiation with Dandelion’s Clinical Development Solutions.
-
Demonstrate superior product differentiation, generate regulatory-grade evidence of economic and clinical outcomes to support reimbursement decisions, and optimize market access strategies using Dandelion’s Post-Approval Solutions.
-
Demonstrate the effectiveness of existing assets across new therapeutic areas with robust, regulatory-grade real world evidence - supporting regulatory submissions and maximizing brand value.
AI Developers
-
Train algorithms on diverse, multi-site datasets that include ground-truth outcomes and expert labels. Dandelion’s RWD platform includes high-fidelity clinical modalities captured in the course of normal clinical practice, enabling a vast array of predictive and prognostic use cases.
-
Validate the performance of existing or work-in-progress algorithms, including checks for bias across geographies, demographics, social determinants of health measures, and machine types. Regular data refreshes allow for prospective studies and post-deployment monitoring for model drift.
-
Generate regulatory-grade real world evidence from rich, representative data to support your FDA approval. Dandelion’s detailed documentation and audit trails facilitate a smooth submission process, allowing you to confidently navigate regulatory requirements and accelerate your time to market.
-
Quantify the clinical and economic impact of your algorithm to demonstrate value to buyers and payers. Dandelion’s diverse longitudinal data enables realistic modeling of the real-world impact of deploying an algorithm in clinical practice on diverse geographies and patient populations.
Built by experienced healthcare leaders and researchers
Featured In
-
![]()
Many people using GLP-1s for weight loss stop treatment too soon, research shows, and results are not one-size-fits-all
-
![]()
Health tech startup Dandelion Health launches data library to advance insights into GLP-1 drugs
-
![]()
Amid the AI gold rush, a new company forms to vet models and root out weaknesses
-
![]()
How This Startup Is Using 10 Million Patient Records To Reduce Bias In Healthcare AI
-
![]()
How AI can power GLP-1’s next frontier in medicine
-
![]()
Weight-loss drugs could become a test case for AI
Recent News from Dandelion
-
[Research] Using AI + RWD to Measure the GLP-1's Real-World Cardioprotective Benefits
-
[Press Release] Dandelion Launches Clinical AI Marketplace to Combine Multimodal RWD with Validated AI
-
[Blog] Measuring GLP-1 Efficacy in the Real World